Free Trial
NYSE:NEUE

NeueHealth (NEUE) Stock Price, News & Analysis

$5.39
+0.07 (+1.32%)
(As of 06/14/2024 ET)
Today's Range
$5.39
$5.69
50-Day Range
$5.32
$6.50
52-Week Range
$4.94
$22.00
Volume
4,057 shs
Average Volume
4,797 shs
Market Capitalization
$44.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

NeueHealth MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
48.4% Upside
$8.00 Price Target
Short Interest
Healthy
0.30% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.50mentions of NeueHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$58,748 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.48 out of 5 stars

Medical Sector

465th out of 914 stocks

Hospital & Medical Service Plans Industry

7th out of 11 stocks

NEUE stock logo

About NeueHealth Stock (NYSE:NEUE)

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

NEUE Stock Price History

NEUE Stock News Headlines

Q1 2024 NeueHealth Inc Earnings Call
NeueHealth Q1 Revenue Drops
NeueHealth: Q1 Earnings Snapshot
NeueHealth Reports First Quarter 2024 Results
NeueHealth CEO sells shares worth over $36k
NeueHealth CEO sells over $41k in company stock
See More Headlines
Receive NEUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2024
Today
6/15/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
N/A
Fax
N/A
Employees
1,252
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+48.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-1,151,450,000.00
Pretax Margin
-51.58%

Debt

Sales & Book Value

Annual Sales
$1.16 billion
Cash Flow
$67.38 per share
Book Value
($158.35) per share

Miscellaneous

Free Float
2,936,000
Market Cap
$44.31 million
Optionable
N/A
Beta
0.78
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Robert John Sheehy (Age 66)
    Co-Founder & Chairman
  • Mr. George Lawrence Mikan III (Age 52)
    Vice Chairman, CEO & President
    Comp: $3.52M
  • Mr. Jay Stephen Matushak (Age 49)
    Chief Financial Officer
    Comp: $950.28k
  • Mr. Tomas Orozco (Age 48)
    Executive Vice President of Consumer Care
    Comp: $1.14M
  • Mr. Jeffrey Joseph Scherman
    Chief Accounting Officer
  • Mr. Jeff Craig (Age 41)
    General Counsel & Corporate Secretary
    Comp: $582.55k
  • Ms. Stacy Conti
    Chief People Officer
  • Mr. Joaquin Baralt M.D.
    President of Value-Based Care

NEUE Stock Analysis - Frequently Asked Questions

Should I buy or sell NeueHealth stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NeueHealth in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NEUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEUE, but not buy additional shares or sell existing shares.
View NEUE analyst ratings
or view top-rated stocks.

What is NeueHealth's stock price target for 2024?

1 analysts have issued 12 month price targets for NeueHealth's stock. Their NEUE share price targets range from $8.00 to $8.00. On average, they expect the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 48.4% from the stock's current price.
View analysts price targets for NEUE
or view top-rated stocks among Wall Street analysts.

How have NEUE shares performed in 2024?

NeueHealth's stock was trading at $6.53 at the beginning of 2024. Since then, NEUE stock has decreased by 17.5% and is now trading at $5.39.
View the best growth stocks for 2024 here
.

Are investors shorting NeueHealth?

NeueHealth saw a decrease in short interest in May. As of May 31st, there was short interest totaling 24,400 shares, a decrease of 16.7% from the May 15th total of 29,300 shares. Based on an average daily volume of 8,900 shares, the short-interest ratio is presently 2.7 days.
View NeueHealth's Short Interest
.

When is NeueHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our NEUE earnings forecast
.

How were NeueHealth's earnings last quarter?

NeueHealth, Inc. (NYSE:NEUE) posted its earnings results on Wednesday, May, 8th. The company reported ($2.31) earnings per share (EPS) for the quarter. The firm had revenue of $245.10 million for the quarter. NeueHealth had a negative net margin of 89.78% and a negative trailing twelve-month return on equity of 5.62%.

How do I buy shares of NeueHealth?

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NEUE) was last updated on 6/16/2024 by MarketBeat.com Staff

From Our Partners